Lymphocyte-dependent inhibition of growth of virulent Mycobacterium tuberculosis H37Rv within human monocytes: Requirement for CD4+ T cells in purified protein derivative-positive, but not in purified protein derivative- negative subjects

Journal of Immunology

Volumn 160, Issue 5, 1998, Pages 2408-2417

  Silver, Richard F ^a,b   Li, Qing ^c   Boom, W Henry ^b   Ellner, Jerrold J ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; EMETINE; GAMMA INTERFERON; NEUTRALIZING ANTIBODY; TUBERCULIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; GROWTH INHIBITION; HELPER CELL; HUMAN; HUMAN CELL; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; SUPPRESSOR CELL; TUBERCULIN TEST;

ADULT; ANTIBODIES, BLOCKING; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION; CELL COMMUNICATION; CELL SEPARATION; CELL SURVIVAL; CELL-FREE SYSTEM; CELLS, CULTURED; HUMANS; IMMUNITY, CELLULAR; INTERFERON TYPE II; INTERLEUKIN-12; INTRACELLULAR FLUID; MIDDLE AGED; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; REPRODUCIBILITY OF RESULTS; TUBERCULIN; TUMOR NECROSIS FACTOR-ALPHA; VIRULENCE;

EID: 0032030591     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Sudre, P., G. ten Dam, and A. Kochi. 1992. Tuberculosis: a global overview of the situation today. Bull. WHO 70:142.
2. Stead, W. W. 1995. Management of health care workers after inadvertent exposure to tuberculosis: a guide for the use of preventative therapy. Ann. Intern. Med. 122:906.
3. Houk, V. N., J. H. Baker, K. Sorensen, and D. C. Kent. 1968. The epidemiology of tuberculosis infection in a closed environment. Arch. Environ. Health 16:26.
4. Orme, I. M. 1987. The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J. Immunol. 138:293.
5. Flynn, J. L., M. M. Goldstein, K. J. Triebold, B. Koller, and B. R. Bloom. 1992. Major histocompatibility complex class I-restricted T cells are required for resistance to Mvcobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 89:12013.
6. Janis, E. M., S. H. E. Kaufmann, R. H. Schwartz, and D. M. Pardoll. 1989. Activation of γδ T cells in the primary immune response to Mycobacterium tuberculosis. Science 244:713.
7. Augustin, A., R. T. Kubo, and G. K. Sim. 1989. Resident pulmonary lymphocytes expressing the γδ receptor. Nature 340:239.
8. Griffin, J. P., K. V. Harshan, W. K. Born, and I. M. Orme. 1991. Kinetics of accumulation of γδ receptor-bearing T lymphocytes in mice infected with live mycobacteria. Infect. Immun. 59:4263.
9. Flesch, I. E. A., and S. H. E. Kaufmann. 1991. Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect. Immun. 59:3213.
10. Chan, J., Y. Xing, R. S. Magliozzo, and B. R. Bloom. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175:1111.
11. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249.
12. Flesch, I. E. A., and S. H. E. Kaufmann. 1990. Activation of tuberculostatic macrophage functions by γ interferon, interleukin-4, and tumor necrosis factor. Infect. Immun. 58:2675.
13. Flynn, J. L., M. M. Goldstein, J. Chan, K. J. Triebold, K. Pfeffer, C. J. Lowenstein, R. Schreiber, T. W. Mak, and B. R. Bloom. 1995. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561.
14. Cooper, A. M., A. D. Roberts, E. R. Rhoades, J. E. Callahan, and I. M. Orme. 1995. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 84:423.
15. Flynn, J. L., M. M. Goldstein, K. J. Triebold, J. Sypek, S. Wolf, and B. R. Bloom. 1995. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 155:2515.
16. Boom, W. H. R. S. Wallis, and K. A. Chervenak. 1991. Human Mycobacterium tuberculosis-reacine CD4+ T-cell clones: heterogeneity in antigen recognition, cytokine production, and cytotoxicity for mononuclear phagocytes. Infect. Immun. 59:2737.
17. Barnes, P. F., J. S. Abrams, S. Lu, P. A. Sieling, T. H. Rea, and R. L. Modlin. 1993. Patterns of cytokine production by mycobacterium-reactive human T cell clones. Infect. Immun. 61:197.
18. + T cells is activated by Mycobacterium tuberculosis but not by its 65-kD heat shock protein. J. Exp. Med. 171:667.
19. Tsuyguchi, I., H. Kawasumi, C. Ueta, I. Yano, and S. Kishimoto. 1991. Increase of T-cell receptor γ/δ-bearing T cells in cord blood of newborn babies obtained by in vitro stimulation with mycobacterial cord factor. Infect. Immun. 59:3053.
20. Havlir, D. V., J. J. Ellner, K. A. Chervenak, and W. H. Boom. 1991. Selective expansion of human γδ T cells by monocytes infected with live Mycobacterium tuberculosis. J. Clin. Invest. 87:729.
21. Johnson, B. L., and D. N. McMurray. 1994. Cytokine gene expression by cultures of human lymphocytes with autologous Mycobacterium tuberculosis-infected monocytes. Infect. Immun. 62:1444.
22. Douvas, G. S., and A. J. Crowle. 1985. γ interferon activates human macrophages to become tumoricidal and leishmaniacidal but enhances replication of macrophage-associated mycobacteria. Infect. Immun. 50:1.
23. Rook, G. A. W., J. Steele, M. Ainsworth, and B. R. Champion. 1986. Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant γ-interferon on human monocytes and murine peritoneal macrophages. Immunology 59:333.
24. Schneemann, M., G. Schoedon, S. Hofer, N. Blau, L. Guerrero, and A. Schaffner. 1993. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J. Infect. Dis. 167:1358.
25. Albina, J. E. 1995. On the expression on nitric oxide synthase by human macrophages: why no NO? J. Leukocyte Biol. 58:643.
26. Schlesinger, L. S. 1993. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J. Immunol. 150:2920.
27. Nakagawara, A., and C. F. Nathan. 1983. A simple method for counting adherent cells: application to cultured human monocytes, macrophages, and multinucleated giant cells. J. Immunol. Methods 56:261.
28. Shiratsuchi, H., B. Hamilton, Z. Toossi, and J. J. Ellner. 1996. Evidence against a role for interleukin-10 in the regulation of growth of Mycobacterium avium in human monocytes. J. Infect. Dis. 173:410.
29. Weaver, C., and E. Unanue. 1986. T cell induction of membrane IL-1 on macrophages. J. Immunol. 137:3868.
30. Crowle, A. J., and M. May. 1981. Preliminary demonstration of human tuberculoimmunity in vitro. Infect. Immun. 31:453.
31. 3 of the multiplication of virulent tubercle in cultured human macrophages. Infect. Immun. 55:2945.
32. Rook, G. A. W., J. Steele, L. Fraher, S. Barker, R. Karmal, and J. O'Riordan. 1986. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 57:159.
33. Crowie, A. J., and E. J. Ross. 1989. Inhibition by retinoic acid of multiplication of virulent tubercle bacilli in cultured human macrophages. Infect. Immun. 57: 1332.
34. Hirsch, C. S., J. J. Ellner, D. G. Russell, and E. A. Rich. 1994. Complement receptor-mediated uptake and tumor necrosis factor-α-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J. Immunol. 152:743.
35. + T lymphocyte subpopulation in tuberculous pleuritis. J. Immunol. 142:1114.
36. Selwyn, P. A., D. Hartel, V. A. Lewis, E. E. Schoenbaum, S. H. Vermund, R. S. Kelin, A. T. Walker, and G. H. Friedland. 1991. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N. Engl. J. Med. 174:583.
37. Barnes, P. F., A. B. Bloch, P. T. Davidson, and D. E. Snider. 1991. Tuberculosis in patients with human immunodeficiency virus infection. N. Engl. J. Med. 324: 1644.
38. Kemp, E. B., R. B. Belshe, and D. F. Hoft. 1996. Immune responses stimulated by percutaneous and intradermal bacille Calmette-Guérin. J. Infect. Dis. 174:113.
39. Bermudez, L. E., M. Wu, and L. S. Young. 1995. Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium. Infect. Immun. 63:4099.
40. Poo, W.-J., L. Conrad, and C. A. Janeway. 1988. Receptor-directed focusing of lymphokine release by helper T cells. Nature 332:378.
41. Panosian, C. B., J. P Sypek, and D. J. Wyler. 1984. Cell contact-mediated macrophage activation for antileishmanial defense. J. Immunol. 133:3358.
42. Kinkhabwala, M., P. Sehajpal, E. Skolnik, D. Smith, V. K. Sharma, H. Vlassara, A. Cerami, and M. Suthanthiran. 1990. A novel addition to the T cell repertory: cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells. J. Exp. Med. 171:941.
43. + T lymphocyte plasma membrane. J. Exp. Med. 174:755.
44. Sypek, J. P., S. Jacobsen, A. Vorys, and D. J. Wyler. 1993. Comparison of gamma interferon, tumor necrosis factor, and direct cell contact in activation of antimycobacterial defense in murine macrophages. Infect. Immun. 61:3901.
45. Webb, D. S., Y. Shimizu, G. A. Van Seventer, S. Shaw, and T. L. Gerrard. 1990. LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release. Science 249:1295.
46. Suttles, J., R. W. Miller, X. Tao, and R. D. Stout. 1994. T cells which do not express membrane tumor necrosis factor-α activate macrophage effector function by cell contact-dependent signaling of macrophage tumor necrosis factor-α production. Eur. J. Immunol. 24:1736.
47. + T-cell contact-dependent activation of monocyte interleukin-1. Eur. J. Immunol. 24:3148.
48. Alderson, M. R., R. J. Armitage, T. W. Tough, L. Strockbine, W. C. Fanslow, and M. K. Spriggs. 1993. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178: 669.
49. Kiener, P. A., P. Moran-Davis, B. M. Rankin, A. F. Wuhl, A. Aruffo, and D. Hollenbaugh. 1995. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J. Immunol. 155:4917.
50. Armant, M., M. Rubio, G. Delespesse, and M. Sarfati. 1995. Soluble CD23 directly activates monocytes to contribute to the antigen-independent stimulation of resting T-cells. J. Immunol. 155:4868.
51. Bonnefoy, J.-Y., C. Plater-Zyberk, S. Lecoanet-Henchoz, J.-F. Guachat, J.-P. Aubry, and P. Graber. 1996. A new role for CD23 in inflammation. Immunol. Today 17:418.
52. + cytotoxic T cell clones. J. Exp. Med. 171:2011.
53. Lorgat, F., M. M. Keraan, P. T. Lukey, and S. R. Ress. 1992. Evidence for in vivo generation of cytotoxic T cells. Am. Rev. Resp. Dis. 145:418.
54. + cytotoxic T cell and relative resistance of alveolar macrophages to lysis. J. Immunol. 159:290.
55. Barnes, P. F., C. L. Grisso, J. S. Abrams, H. Band, T. H. Rea, and R. L. Modlin. 1992. γδ T lymphocytes in human tuberculosis. J. Infect. Dis. 165:506.
56. + αβ T cell and γδ T cell responses to Mycobacterium tuberculosis: similarities and differences in antigen recognition, cytotoxic effector function, and cytokine production. J. Immunol. 154:1786.
57. Malloy, A., P. Laochumroonvorapong, and G. Kaplan. 1994. Apoptosis, but not necrosis, of infected monocytes coupled with killing of intracellular bacillus Calmette-Guérin. J. Exp. Med. 180:1499.
58. Stenger, S., R. J. Mazzaccaro, K. Uyemura, S. Cho, P. F. Barnes, J.-P. Rosat, A. Sette, M. B. Brenner, S. A. Porcelli, B. R. Bloom, and R. L. Modlin. 1997. Differential effects of cytolytic T cell subsets on intracellular infection. Science 276:1684.